Aimee D Shu

17PUBLICATIONS
36CO-AUTHORS
Toxicology (incl. clinical toxicology)Gene and molecular therapyImmunogenetics (incl. genetic immunology)Clinical pharmacy and pharmacy practiceCounselling, wellbeing and community services
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 27, 2026
Palopegteriparatide in Adults With Hypoparathyroidism: 3.5-Year Results From the Phase 3 PaTHway Trial.

|Oct 26, 2026
Efficacy and Safety of Lonapegsomatropin in Children With Turner Syndrome: 52-Week Results From the New InsiGHTS Trial.

|Sep 22, 2026
Immunogenicity Profile of Lonapegsomatropin During Long-Term Treatment in Children With Growth Hormone Deficiency.

|Jul 13, 2026
Pharmacodynamics of sustained levels of PTH following palopegteriparatide treatment in adults with hypoparathyroidism.

|May 21, 2026
Sustained improvement in renal function with palopegteriparatide in adults with chronic hypoparathyroidism: 2-year results from the phase 3 PaTHway-trial.

|Feb 04, 2026
Palopegteriparatide for adults with chronic hypoparathyroidism: skeletal dynamics through 3 years of the phase 2 PaTH forward trial.

Mishaela R Rubin, Bart L Clarke, Lorenz C Hofbauer

Pageof 3

Frequent Collaborators

6 joint publications

Andrea Palermo

4 joint publications

Aliya Khan

4 joint publications

Peter Schwarz

4 joint publications

Claudia Gagnon